InVivo Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • NVIV
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.52
  • (As of Friday Closing)

InVivo Therapeutics General Information

Description

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • One Kendall Square
  • Building 1400 East, Floor 4
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InVivo Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.52 $0.51 $0.42 - $2.00 $17.7M 34.3M 687K $0.48

InVivo Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,928 10,345 (3,038) (5,439)
Revenue 0 0 0 0
EBITDA (8,817) (8,764) (11,762) (23,538)
Net Income (9,175) (9,074) (11,830) (23,423)
Total Assets 23,573 21,910 9,325 18,377
Total Debt 914 1,020 1,314 100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InVivo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InVivo Therapeutics‘s full profile, request access.

Request a free trial

InVivo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on
Therapeutic Devices
Cambridge, MA
6 As of 2020
000.00
00000000 000.00

000000 0

ptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
00000000000 0000000
Ardsley, NY
000 As of 0000
00000
0.00 0000-00-00
000000&0

00000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
00000000 0000000
Clarksville, TN
00 As of 0000
000.00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InVivo Therapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acorda Therapeutics Formerly VC-backed Ardsley, NY 000 00000 000000&0
000000000 0000000 Private Equity-Backed Clarksville, TN 00 000.00 00000000000
00000 000000000000 Private Equity-Backed Lausanne, Switzerland 00 000.00 0000000 0000 000.00
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
00000000 Angel-Backed New York, NY 0 00000 0000000000 0 00000
You’re viewing 5 of 5 competitors. Get the full list »

InVivo Therapeutics Patents

InVivo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170151416-A1 Methods and systems for delivery of a trail of a therapeutic substance into an anatomical space Abandoned 01-Dec-2015 00000000000 00
US-20170151286-A1 Compositions and methods for preparing an injectable medium for administration into the central nervous system Abandoned 01-Dec-2015 000000000
US-20170304453-A1 Thiol-ene functionalized hydrogels Abandoned 05-Sep-2014 000000000
US-20140012314-A1 Cupped forceps Abandoned 29-Jun-2012 00000000000 00
US-20130233736-A1 Protective packaging with product preparation features incorporated Abandoned 09-Mar-2012 B65D81/22 00
To view InVivo Therapeutics’s complete patent history, request access »

InVivo Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
Richard Toselli MD Chief Executive Officer & Board Member
Richard Christopher Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Joseph Vacanti MD Co-Founder
William D'Agostino Senior Vice President, Operations
Robert Langer Ph.D Co-Founder
You’re viewing 5 of 14 executive team members. Get the full list »

InVivo Therapeutics Board Members (7)

Name Representing Role Since
C. Merrifield Self Chairman & Board Member 000 0000
Christina Morrison Self Board Member 000 0000
Daniel Marshak Ph.D InVivo Therapeutics Board Member 000 0000
Richard Roberts Ph.D Self Board Member 000 0000
Richard Toselli MD InVivo Therapeutics Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

InVivo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InVivo Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InVivo Therapeutics‘s full profile, request access.

Request a free trial

InVivo Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 26-Oct-2010 0000000000 Other Commercial Services
To view InVivo Therapeutics’s complete acquisitions history, request access »